High affinity humanized anti-TAG-72 monoclonalantibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 19, 2002
Grant Date -
N/A
app pub date -
Feb 18, 1998
filing date -
Oct 31, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Novel humanized monoclonal antibodies, humanized antibody fragments, and derivatives thereof which specifically bind TAG-72 are provided as well as methods for their manufacture. These humanized antibodies are useful in the treatment of cancers which express TAG-72 as well as for diagnostic purposes, e.g., for in vivo imaging of tumors or cancer cells which express TAG-72.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully